Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juli 2017

Planlagt Fastgjort Låst Flyttet Genmab
985 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #966

    Jo peaksale på 9B USD men ikke i 2020

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #967

      hov - blev lige afbrud - jo 2025-2027 stykker

      1 Reply Last reply
      0
      • StockBullS Offline
        StockBullS Offline
        StockBull
        wrote on sidst redigeret af
        #968

        Beklager min fejl information. Det Michael Novod har informeret at M.M markedet vil være ca. 9B USD i 2020 og det er sikkert revideret efter denne artikel fra 2013 http://www.firstwordpharma.com/node/1066623?tsid=21#axzz4oOXUDX45

        1 Reply Last reply
        0
        • G Offline
          G Offline
          gentogen
          wrote on sidst redigeret af
          #969

          The global multiple myeloma therapeutics market was valued at USD 7.5 billion in 2015 and is expected to reach a value of USD 37.5 billion by 2024. Key factors driving the market expansion include constant introduction of newer and effective therapeutic options and high adoption rates of the same.

          1 Reply Last reply
          0
          • G Offline
            G Offline
            gentogen
            wrote on sidst redigeret af
            #970

            Just a moment...

            favicon

            (www.grandviewresearch.com)

            1 Reply Last reply
            0
            • G Offline
              G Offline
              gentogen
              wrote on sidst redigeret af
              #971

              Men der er mange bud.....http://www.fiercepharma.com/marketing/global-multiple-myeloma-treatment-market-value-to-approach-9-billion-by-2021-says-gbi

              1 Reply Last reply
              0
              • H Offline
                H Offline
                Her_for_at_lære
                wrote on sidst redigeret af
                #972

                Der er an meget afventende handel med Genmap. Er det mon udtryk for en afventen med hensyn til halvårsregnskabet den 9. Aug?

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #973

                  Sommerferie...

                  1 Reply Last reply
                  0
                  • H Offline
                    H Offline
                    Her_for_at_lære
                    wrote on sidst redigeret af
                    #974

                    OK 🙂

                    1 Reply Last reply
                    0
                    • T Offline
                      T Offline
                      transalp
                      wrote on sidst redigeret af
                      #975

                      favicon

                      (www.bloodjournal.org)

                      1 Reply Last reply
                      0
                      • J Offline
                        J Offline
                        JKY_VH
                        wrote on sidst redigeret af
                        #976

                        God eftermiddag. Der er nok at glæde sig til i den kommende tid: Q3-2017: Darzalex ph III ALCYONE frontline MM data with Velcade
                        H2 2017: ESMO Congress – 8-12 September
                        H2 2017: Ph II data for Tisotumab Vedotin (likely at ESMO)
                        H2 2017: Darzalex Ph II data in high-risk smouldering myeloma
                        (CENTAURUS study) likely in Q4 (ASH)
                        H2 2017: Darzalex ph II data in multiple myeloma with Celgene’s
                        durvalumab
                        H1 2018: Darzalex ph III MAIA frontline MM data with Revlimid

                        1 Reply Last reply
                        0
                        • J Offline
                          J Offline
                          JKY_VH
                          wrote on sidst redigeret af
                          #977

                          H1 2018: Darzalex ph Ib/II data in solid tumours with Roche's
                          checkpoint inhibitor Tecentriq
                          H2 2018: Darzalex ph Ib/II data in solid tumours with BMS's
                          checkpoint inhibitor Opdivo.
                          Kilde: Nordea

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #978

                            Since you mentioned durvalumab, had news today: IMFINZI™ (durvalumab) granted Breakthrough Therapy Designation by US FDA for patients with locally advanced unresectable non-small cell lung cancer https://www.astrazeneca-us.com/media/press-releases/2017/imfinzi-durvalumab-granted-breakthrough-therapy-designation-by-us-fda-for-patients-with-locally-advanced-unresectable-non-small-cell-lung-cancer-07312017.html

                            1 Reply Last reply
                            0
                            • J Offline
                              J Offline
                              JKY_VH
                              wrote on sidst redigeret af
                              #979

                              Thank you E L

                              1 Reply Last reply
                              0
                              • DarvinD Offline
                                DarvinD Offline
                                Darvin
                                wrote on sidst redigeret af
                                #980

                                Mht snakken ca kl 10.00 - Novod forventer Dara passerer 5,3 mia i salg 2021 alene i MM. CITI at knap 6 mia passeres i 2021 også i MM. CITI siger totalmarked i 2025 for US (MM) alene vil være 28 mia $ og at verdensmarkedet umiddelbart (normalt) bliver det dobbelte!! (46 mia). Så kan man jo tænke lidt på markedsandel for DARA. CITI regner med 11 mia i topsalg for Dara, men der er mange faktorer

                                1 Reply Last reply
                                0
                                • M Offline
                                  M Offline
                                  Mcjean
                                  wrote on sidst redigeret af
                                  #981

                                  11 mia$ eller?, altså omkring 18% af 70 mia, ca. 13 mia kr. ved markedsandel på ca. 25%, lavt sat hvis sc og vedligeholdelse medregnes og udløb af to patenter. For 13 mia kr. om året kan der nok købes en del, måske en ny fabrik måske:-)

                                  1 Reply Last reply
                                  0
                                  • B Offline
                                    B Offline
                                    bibob
                                    wrote on sidst redigeret af
                                    #982

                                    Ja Mcjean. Mon ikke pølsemanden havde råd til at modernisere pølsevognen hvis han havde den omsætning. 😄

                                    1 Reply Last reply
                                    0
                                    • B Offline
                                      B Offline
                                      bikube
                                      wrote on sidst redigeret af
                                      #983

                                      Mcjean - skal du over knæet - fy skam dig.

                                      1 Reply Last reply
                                      0
                                      • I Offline
                                        I Offline
                                        ienk1
                                        wrote on sidst redigeret af
                                        #984

                                        Måske Lisa som konsulent i indkørselsfasen 😉

                                        1 Reply Last reply
                                        0
                                        • I Offline
                                          I Offline
                                          ienk1
                                          wrote on sidst redigeret af
                                          #985

                                          Med

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger